EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
-14.41%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$127M
AUM Growth
+$127M
(-17%)
Cap. Flow
-$2.57M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
51.19%
Holding
54
New
8
Increased
17
Reduced
15
Closed
8
Top Buys
| 1 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$2.71M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$2.58M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$2.56M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$2.23M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$1.98M |
Top Sells
| 1 |
DBVT
DBV Technologies
DBVT
|
$3.11M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$2.96M |
| 3 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$2.64M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$2.58M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$2.54M |
Sector Composition
| 1 | Healthcare | 48.32% |
| 2 | Financials | 34.37% |
| 3 | Consumer Discretionary | 6.74% |
| 4 | Industrials | 2.63% |
| 5 | Real Estate | 1.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
26
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.92M | 1.51% | 19,667 -3,348 | -15% | -$326K |
|
|
DRNA
27
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.84M | 1.45% | +172,524 | New | +$1.84M |
|
28
Solid Biosciences
SLDB
$427M
| $1.84M | 1.45% | 68,714 -1,071 | -2% | -$28.7K |
|
29
Neurocrine Biosciences
NBIX
$13.8B
| $1.81M | 1.42% | 25,289 +1,804 | +8% | +$129K |
|
|
AMRN
30
Amarin Corp
AMRN
$311M
| $1.76M | 1.39% | +129,393 | New | +$1.76M |
|
|
IMMU
31
DELISTED
Immunomedics Inc
IMMU
| $1.76M | 1.38% | 123,101 -2,151 | -2% | -$30.7K |
|
32
CBRE Group
CBRE
$48.2B
| $1.74M | 1.37% | 43,532 -2,085 | -5% | -$83.5K |
|
33
Morgan Stanley
MS
$240B
| $1.7M | 1.34% | 42,743 -1,988 | -4% | -$78.8K |
|
34
KKR & Co
KKR
$124B
| $1.69M | 1.33% | 85,941 +1,455 | +2% | +$28.6K |
|
35
Seagate
STX
$35.6B
| $1.69M | 1.33% | 43,663 +4,084 | +10% | +$158K |
|
36
Trinity Industries
TRN
$2.3B
| $1.68M | 1.33% | 81,739 +22,841 | +39% | +$470K |
|
37
Armstrong World Industries
AWI
$8.47B
| $1.66M | 1.31% | 28,514 -2,478 | -8% | -$144K |
|
38
Citigroup
C
$178B
| $1.52M | 1.19% | 29,095 -1,511 | -5% | -$78.7K |
|
39
SLM Corp
SLM
$6.52B
| $1.49M | 1.17% | 179,133 -5,680 | -3% | -$47.2K |
|
40
Bread Financial
BFH
$3.09B
| $1.43M | 1.12% | 9,509 +526 | +6% | +$78.9K |
|
|
LJPC
41
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.41M | 1.11% | 149,013 +31,537 | +27% | +$297K |
|
42
Bausch Health
BHC
$2.74B
| $1.36M | 1.07% | +73,529 | New | +$1.36M |
|
|
SMC
43
Summit Midstream Corporation
SMC
$282M
| $880K | 0.69% | 87,560 | – | – |
|
44
Cocrystal Pharma
COCP
$15.4M
| $550K | 0.43% | 152,916 | – | – |
|
45
Amazon
AMZN
$2.44T
| $237K | 0.19% | 158 | – | – |
|
46
SPDR S&P 500 ETF Trust
SPY
$658B
| $218K | 0.17% | 872 | – | – |
|
|
DBVT
47
DBV Technologies
DBVT
$264M
| – | – | -138,447 | Closed | -$3.11M |
|
|
SAGE
48
DELISTED
Sage Therapeutics
SAGE
| – | – | -17,998 | Closed | -$2.54M |
|
49
TG Therapeutics
TGTX
$4.65B
| – | – | -231,989 | Closed | -$1.3M |
|
|
MNTA
50
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| – | – | -98,084 | Closed | -$2.58M |
|